Formulation and evaluation of microbially triggered compression coated tablets of ketorolac tromethiamine

Der Pharmacia Lettre

Volumn 3, Issue 4, 2011, Pages 29-39

  Chithaluru, Kalyani ^a   Tadikonda, Rama Rao ^b  

^a CHALAPATHI INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

^b Blue Birds College of Pharmacy   (India)

Author keywords

Colon target; Ketorolac tromethiamine; Metalose 90SH; Microbial degradation

Indexed keywords

GALACTOMANNANASE; GUAR GUM; INTESTINE ENZYME; KETOROLAC TROMETAMOL; METALOSE 90 SH; MICROCRYSTALLINE CELLULOSE; POLYMER; STARCH GLYCOLATE SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COLON; COMPRESSION COATED TABLET; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DISSOLUTION; DRUG COATING; DRUG DEGRADATION; DRUG DOSAGE FORM COMPARISON; DRUG RELEASE; DRUG RELEASE KINETICS; DRUG STABILITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; KINETICS; MALE; NON FICKIAN DIFFUSION; NONHUMAN; RAT; SIMULATION; STOMACH JUICE; STOMACH PH; TABLET COAT THICKNESS; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET DRUG CONTENT; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET PROPERTY; TABLET WEIGHT VARIATION; THICKNESS;

EID: 80052856556     PISSN: None     EISSN: 09755071     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Asqhar LF and Chandran S., J. Pharm. Pharm. Sci., 9(3): 2006, 327-338.
2. Sinha VR, Kumria R., Pharm Res 18: 2001, 557-564.
3. Dew MJ, Hughes PJ, Lee MG, Evans BK, Rhodes J., Br J Clin Pharmacol., 14: 1982, 405-408.
4. Chourasia MK, Jain SK., J Pharm Pharmaceut Sci., 6(1): 2003, 33-66.
5. Kinget R, Van-Den-Mooter G, Samyn C., International journal of Pharmaceutics, 93: 1993, 133-139.
6. Ramprasad Y V, Krishnaiah Y S, SatyanarayanaS., Drug development and industrial pharmacy, 25(5): 1999, 651-657.
7. V.R. Sinha, B.R. Mittal and Rachna Kumria., International Journal of Pharmaceutics, 289 (1-2): 2005, 79-85.
8. Milojevic S, Newton JM, Cummings JH, GibsonGR, Botham RL, Ring SC, Stockham M, Allwood MC., J Control Rel., 38: 1996,85-94.
9. Ashford M, Fell JT, Attwood D, Sharma H, Woodhead P., J Control Rel, 30: 1994, 225-232.
10. Rubinstein A, Nakar D, Sintov A., Int J Pharm., 84: 1992,141-150.
11. Tozaki H, Komoike J, Tada C, Maruyama T, Terabe A, Suzuki T, Yamamoto A, Muranishi S., J Pharm Sci., 86: 1997, 1016-1021.
12. Krishnaiah YSR, Seetha Devi A, Nageswara RaoL, Bhaskar Reddy PR, Karthikeyan RS, Satyanarayana V., JPharm Pharmaceutics Sci., 4: 2001, 235-243.
13. Krishnaiah YSR, Satyanarayana S, Rama Prasad YV, Narasimha Rao S., J Control Rel., 55: 1998, 245-252.
14. Munira M, Punarikakshudu K., Drug Deliv Techno.l, 6: 2004, 54-61.
15. Rama Prasad YV, Krishnaiah YSR, Satyanarayana S., J Control Rel., 51: 1998, 281-287.
16. Goodman, Gilman. Goodman and Gilman's the pharmacological basis of therapeutics. 10th ed. NY: McGraw-Hill; 2001: 871-872.
17. The United States Pharmacopoeia 23 NF 18, The United States Pharmacopoeial Convention, Rockville, MD, 2000, 1942
18. Rama Prasad, Y.V., Krishnaiah, Y.S.R., Satyanarayanta., S., J. Control. Release, 51: 1998, 281-287.
19. J. W. Moore and H. H. Flanner., Pharm. Tech. 20:1996, 64-74.
20. T. Higuchi., Pharm. Sci. 50:1961, 874-875.
21. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas., Int. J. Pharm.,15:1983 25-35
22. Note for guidance on stability testing: Stability testing of new drug substances and products. 2003. [Online].Cited 2006 August 27]; Available from URL:http:// www.ich.org/cache/compo/363-272-1.